The American Association for Cancer Research (AACR), on behalf of Stand Up To Cancer (SU2C), Cancer Research UK, and the Lustgarten Foundation calls upon members of the cancer community to contribute their ideas to the groundbreaking Stand Up to Cancer-Cancer Research UK-Lustgarten Foundation Pancreatic Cancer Dream Team Translational Research Grant.
We invite the submission of ideas for a translational cancer research project that will address critical problems in pancreatic cancer and positively impact patients in the near future. The project should include interventions in prevention, diagnosis, or treatment of pancreatic cancer, and deliver near-term patient benefit through investigation by a multidisciplinary, multi-institutional, transatlantic, synergistic Dream Team of expert investigators. The project must be designed to accelerate therapeutic application to the clinic (i.e., lead to patient involvement within 2-3 years from the beginning of the grant). Proposals for this Dream Team research project must present plans indicating how the work will be translated into the clinic. The ideas should be based on perceived opportunities for success as well as high-priority areas with a critical need for rapid progress beyond current medical care.
Letters of Intent will be reviewed by the SU2C-Cancer Research UK-Lustgarten Foundation Joint Scientific Advisory Committee (JSAC), and Teams with the most promising idea submissions will be invited to submit full proposals. The JSAC will select an SU2C-Cancer Research UK-Lustgarten Foundation Pancreatic Cancer Dream Team from the invited proposals. The SU2C-Cancer Research UK-Lustgarten Foundation Pancreatic Cancer Dream Team will be awarded up to $12 million over the 3-year term of the grant.